Filtered By:
Condition: Overactive Bladder Syndrome
Drug: Oxybutynin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study
ConclusionsWe did not identify differences in the risk of cardiovascular events or mortality among users of individual antimuscarinic OAB drugs.
Source: European Journal of Clinical Pharmacology - November 13, 2017 Category: Drugs & Pharmacology Source Type: research
